United Bank (Virginia)’s Adamas Pharmaceuticals ADMS Stock Holding History

United Bank (Virginia)’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,200	Closed	-$55K	–	168
2021 Q3	$55K	Buy	+11,200	New	+$54.4K	0.01%	160

United Bank (Virginia)'s ADMS Position: Q4 2021 in Review

United Bank (Virginia) sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 11,200 shares — an estimated $55K sold.

United Bank (Virginia) first reported a position in ADMS in Q3 2021 and held it in 1 quarter. The position peaked at $55K in Q3 2021. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

United Bank (Virginia) reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
United Bank (Virginia) sold 11,200 Adamas Pharmaceuticals shares in Q4 2021, an estimated $55K.
United Bank (Virginia) first reported a position in Adamas Pharmaceuticals in Q3 2021 and held it in 1 quarter.
United Bank (Virginia)'s Adamas Pharmaceuticals position peaked at $55K in Q3 2021.
0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on United Bank (Virginia)'s 13F filing for Q4 2021, filed 11 Feb 2022.